Exelixis, Inc.

EXEL·NasdaqGS·Healthcare
Compare
72.75+0.44 (+0.61%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close72.31
Open73.18
Day range71.3173.41
52-week range38.1973.44
Off day high−0.90%
Off 52-week high−0.94%
Volume2.85M
Avg. volume (3M)2.42M
Market cap17.75B
EPS (TTM)3.34
Forward P/E17.02
P/E ratio (TTM)21.78
Dividend yield—
Beta (5Y)0.42
Shares outstanding244.01M
Short interest15.33% of float
Earnings dateOct 29, 2026
Analyst target61.36
Profit margin35.45%

Against its peers

Compare in full ›
EXEL 688266.SS NUVL 2616.HK 9969.HK SMMT
Market cap 17.75B 24.15B — 8.98B 21.56B 12.90B
P/E (TTM) 21.8 42.6 — — 20.3 —
Forward P/E 17.0 73.0 — 137.0 53.2 -13.8
Price/book 9.7 14.1 — 5.9 1.9 19.0
Dividend yield — — — — — —
1-year change +79.12% −10.38% — −7.84% −14.61% −12.56%
Today +0.61% +0.12% 0.00% +4.16% +1.33% +2.34%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Exelixis's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Suzhou Zelgen Biopharmaceuticals Co., Ltd.688266.SS · Biotechnology 24.15B 91.25 +0.12%
Nuvalent IncNUVL · Biotechnology 9.81B 123.96 0.00%
CStone Pharmaceuticals2616.HK · Biotechnology 8.98B 5.635 +4.16%
InnoCare Pharma Limited9969.HK · Biotechnology 21.56B 12.200 +1.33%
Summit Therapeutics Inc.SMMT · BiotechnologyOdds 12.90B 16.17 +2.34%
Arcus Biosciences, Inc.RCUS · Biotechnology 2.43B 19.31 +2.12%
Alphamab Oncology9966.HK · Biotechnology 6.43B 6.655 +1.68%
RemeGen Co., Ltd.9995.HK · Biotechnology 40.23B 71.300 +1.49%

Also based in Alameda, California, then elsewhere in California.

Company Mkt cap Price Today
Penumbra, Inc.PEN · Alameda, CA 12.71B 322.45 +0.76%
Scribe Therapeutics Inc.SCTX · Alameda, CA 317.67M 16.78 +3.58%
Vivani Medical, Inc.VANI · Alameda, CA 96.52M 1.0700 +1.90%
NVIDIA CorporationNVDA · Santa Clara, CAOdds 4.83T 200.13 −3.17%
Apple Inc.AAPL · Cupertino, CAOdds 5.08T 349.51 +5.31%
Meta Platforms, Inc.META.BA · Menlo Park, CA 112.71T 44,080.00 +1.99%
Broadcom Inc.AVGOCL.SN · Palo Alto, CA 1,519.49T 318,310.00 0.00%
The Walt Disney CompanyDISN.BA · Burbank, CA 228.48T 16,540.00 +4.16%

The stocks whose daily moves over the past year went most closely with Exelixis's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Incyte CorporationINCY · Correlation 0.54 25.04B 122.85 +4.47%
Neurocrine Biosciences, Inc.NBIX · Correlation 0.50 16.81B 166.05 +0.73%
Mirum Pharmaceuticals, Inc.MIRM · Correlation 0.46 6.30B 96.97 +11.42%
Vertex Pharmaceuticals IncorporatedVRTX · Correlation 0.39 139.16B 549.04 +3.44%
Acadia Pharmaceuticals Inc.ACAD · Correlation 0.36 3.70B 21.47 +4.38%
Halozyme Therapeutics, Inc.HALO · Correlation 0.33 14.79B 130.34 +1.34%

What visitors to Exelixis's page also look at.

Company Mkt cap Price Today
Incyte CorporationINCY 25.04B 122.85 +4.47%
BioMarin Pharmaceutical Inc.BMRN 11.06B 57.13 +2.64%
ACADIA Pharmaceuticals Inc.ACAD 3.70B 21.47 +4.38%
Neurocrine Biosciences, Inc.NBIX 16.81B 166.05 +0.73%
Vertex Pharmaceuticals IncorporVRTX 139.16B 549.04 +3.44%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All EXEL news ›
Multibagg AI·Positive

Exxaro Tiles Limited revenue rises 62% as profit doubles

Exxaro Tiles Limited reported consolidated total income from operations of Rs 112.28 crore for the quarter ended 30 September 2026, up 62.3% from Rs 69.16 crore a year earlier, while profit after tax more than doubled to Rs 3.07 crore from…

EXEL
FXEmpire·Positive

Exelixis Rises with Earnings on Tap

Shares of oncology company Exelixis, Inc. (EXEL) are higher by 177% since 2017. It’s no wonder EXEL shares are up 42% so far this year – and they could rise more. MoneyFlows data shows how Big Money investors are betting heavily on the…

EXELNVDA
Trefis·

What Was Exelixis Telling You Before Its Stock Ran?

Shares of Exelixis (EXEL) returned 76.0% between October 29, 2025, and October 30, 2026, compared with 11.3% for the S&P 500. During that year, the FDA accepted the company’s application for its experimental cancer drug zanzalintinib.…

EXELLLYNVOPFE

From the 4Search news index, newest first.

In the news

31mentions in 30 days
22with it in the headline
Positivesentiment

Mentioned with

Investors & News18Exelixis, Inc.17Twitter17Facebook16Exelon15Expeditors8Royal Bank of Canada8Biospace Exelixis7

People in the coverage

Tristan Rich19Danessa Lincoln17Marketbeat16Benzinga14Mitch Edgeman14Chris Tyson8

Themes

Healthcare14Earnings11Financial8Consensus7Industrial7Ratings7SA Transcripts6EPS5

Most coverage from

  1. themarketsdaily.com6
  2. marketscreener.com5
  3. seekingalpha.com5
  4. multibagg.ai2
  5. tradingview.com2

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 31 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance